利用血栓形成和出血的风险评估来优化非膜性心房的抗凝策略
Yue Zhao1, Li-Ya Cao1, Ying-Xin Zhao2
1Department of Pharmacy, The First Affiliated Hospital of Army Medical University (Third Military Medical University), Chongqing, P. R. China.
Thrombosis and haemostasis
|August 13, 2024
概括
机器学习模型可以预测非膜性心房动 (NVAF) 患者进行导管切除 (CA) 的血栓形成和出血风险. 这些工具的目的是准确的抗凝策略,改善患者的治疗结果和安全.
科学领域:
- 计算医学和心脏病学.
- 临床数据科学和机器学习应用程序
背景情况:
- 口服抗凝剂 (OAC) 在导管切除 (CA) 后对于非膜性心房动 (NVAF) 来预防血栓形成至关重要.
- 不适当使用OAC不提供中风预防益处,并增加出血风险.
- 需要精确的抗凝策略来平衡NVAF患者的疗效和安全.
研究的目的:
- 开发和比较机器学习 (ML) 模型,用于预测CA.后NVAF患者的血栓形成和出血风险.
- 建立基于数据的,精确的抗凝血策略.
- 确定影响血栓形成和出血事件的关键风险因素.
主要方法:
- 从2015年至2023年接受CA的1,055名NVAF患者的回顾性分析.
- 八个ML算法的比较,用于预测血栓和出血.
- 使用特征重要性和夏普利添加式解释 (SHAP) 的模型解释.
主要成果:
- XGBoost模型显示了最高的性能:血栓形成的精度为0.740,出血的精度为0.781.
- 血栓形成的主要预测因素:年龄,BNP,肝素持续时间.
- 主要出血预测因素:抗凝血策略,BNP,脂质.
- 优化模型 (血栓形成的RF-T,出血的Xw-B) 实现了高回忆率 (分别为0.774和0.780).
结论:
- 优化的ML模型显示,在CA后的NVAF患者中预测血栓和出血具有显著的潜力.
- 这些模型可以指导个性化的抗凝策略,增强患者护理.
- 这些发现可能成为未来临床风险分层分数的基础.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
654
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
654
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
501
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
501
Clot Retraction and Fibrinolysis
5.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.0K


